| LPTX Stock | | | USD 0.50 0.01 1.96% |
This module uses fundamental data of Leap Therapeutics to approximate its Piotroski F score. Leap Therapeutics F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Leap Therapeutics. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Leap Therapeutics financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Leap Therapeutics Altman Z Score,
Leap Therapeutics Correlation,
Leap Therapeutics Valuation, as well as analyze
Leap Therapeutics Alpha and Beta and
Leap Therapeutics Hype Analysis.
For more information on how to buy Leap Stock please use our
How to Invest in Leap Therapeutics guide.
At this time, Leap Therapeutics'
Net Debt To EBITDA is fairly stable compared to the past year.
Debt To Equity is likely to rise to 0 in 2025, despite the fact that
Net Debt is likely to grow to (60.2
M). At this time, Leap Therapeutics'
Income Quality is fairly stable compared to the past year.
Net Debt To EBITDA is likely to rise to 0.86 in 2025, whereas
PTB Ratio is likely to drop 1.41 in 2025.
At this time, it appears that Leap Therapeutics' Piotroski F Score is Unavailable. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score - Unavailable
| Change in Return on Assets | |
| Cash Flow Return on Assets | |
| Current Quality of Earnings (accrual) | |
| Long Term Debt Over Assets Change | |
| Change In Outstending Shares | |
Leap Therapeutics Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Leap Therapeutics is to make sure Leap is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Leap Therapeutics' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Leap Therapeutics' financial numbers are properly reported.
Leap Therapeutics F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical
financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Leap Therapeutics' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Leap Therapeutics in a much-optimized way.
Click cells to compare fundamentals
About Leap Therapeutics Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Leap Therapeutics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Leap Therapeutics from analyzing Leap Therapeutics' financial statements. These drivers represent accounts that assess Leap Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Leap Therapeutics' important valuation drivers and their relationship over time.
About Leap Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Leap Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Leap Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Leap Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Leap Stock Analysis
When running Leap Therapeutics' price analysis, check to
measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.